BRIM Biotechnology, Inc. (TPE:6885)

BRIM Biotechnology Revenue

BRIM Biotechnology had revenue of 3.17M TWD in the quarter ending September 30, 2026, with 158.18% growth. This brings the company's total for the last twelve months to 12.55M, up 295.59% year-over-year. In the year 2025, BRIM Biotechnology had annual revenue of 5.49M with 1,548.65% growth. That makes BRIM Biotechnology the 44,881st largest company in the world by revenue and 2,182nd in Taiwan.

• Revenue (ttm): 12.55M
• Revenue Growth: +295.59%
• P/S Ratio: 308.58
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 3.87B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Quanfu 4.12M 75.1%
• Pepsico and Its Subsidiaries 1.37M 24.9%

By Geography

Chart

• Taiwan 5.00M 91.0%
• Japan 495.00K 9.0%

Fiscal year ended Dec 31, 2025 See the full BRIM Biotechnology breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	5.49M	5.16M	1,548.65%
Dec 31, 2024	333.00K	243.00K	270.00%
Dec 31, 2023	90.00K	-436.00K	-82.89%
Dec 31, 2022	526.00K	166.00K	46.11%
Dec 31, 2021	360.00K	-90.41M	-99.60%

Data Source: S&P Global Market Intelligence Last updated: Nov 10, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 12, 2026

Data Sources Report a data error